Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 5/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.52 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.52 |
| ▸ | COPS5 | Q92905 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | USP2 | O75604 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18848335 | 0.84 | HTR1A (0.56) | MEN1KMT2ASMN1; SMN2HSP90AA1L3MBTL1 | |
| SCHEMBL18757318 | 0.84 | HTT (0.61) | MEN1KMT2ASMN1; SMN2HSP90AA1L3MBTL1 | |
| SCHEMBL18840389 | 0.83 | HSP90AA1 (0.57) | MEN1KMT2ASMN1; SMN2HSP90AA1L3MBTL1 | |
| SCHEMBL812451 | 0.83 | HTT (0.70) | MEN1KMT2ASMN1; SMN2HSP90AA1L3MBTL1 | |
| SCHEMBL2056205 | 0.76 | KDM4E (0.61) | MEN1KMT2ASMN1; SMN2HSP90AA1L3MBTL1 | |
| SCHEMBL21130214 | 0.76 | PSMD14 (0.72) | MEN1KMT2ASMN1; SMN2HSP90AA1L3MBTL1 | |
| SCHEMBL2002972 | 0.76 | HTT (0.72) | MEN1KMT2ASMN1; SMN2HSP90AA1L3MBTL1 | |
| SCHEMBL113423 | 0.76 | KDM4E (0.61) | MEN1KMT2ASMN1; SMN2HSP90AA1L3MBTL1 | |
| SCHEMBL12332383 | 0.76 | MEN1 (0.53) | MEN1KMT2ASMN1; SMN2HSP90AA1L3MBTL1 | |
| SCHEMBL2557719 | 0.76 | L3MBTL1 (0.61) | MEN1KMT2ASMN1; SMN2HSP90AA1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11818932-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-14 | — | — | US | disclosed |
| US-20230320981-A1 | SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS | INTERVET INC. (US) | 2023-10-12 | — | — | US | disclosed |
| US-11712416-B2 | Solid oral pharmaceutical compositions for isoxazoline compounds | INTERVET INC. (US) | 2023-08-01 | — | — | US | disclosed |
| US-11690289-B2 | Organic compound containing heterocyclic ring and having low lumo properties, and organic electroluminescent device using the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| WO-2023280177-A1 | SMALL MOLECULE COMPOUND TARGETING BCL9/β-CATENIN INTERACTION | 南通聚太生物科技有限公司 | 2023-01-12 | — | — | WO | disclosed |
| US-11329230-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-05-10 | — | — | US | disclosed |
| US-11179372-B2 | Isoxazoline solution containing vitamin E for use with sanitized drinking water | INTERVET INC. (US) | 2021-11-23 | — | — | US | disclosed |
| US-11165024-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-11-02 | — | — | US | disclosed |
| US-20210320154-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-10-14 | — | — | US | disclosed |
| US-20210167296-A1 | ORGANIC COMPOUND CONTAINING HETEROCYCLIC RING AND HAVING LOW LUMO PROPERTIES, AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2021-06-03 | — | — | US | disclosed |
| US-20170179204-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-22 | — | — | US | disclosed |
| US-20170179401-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-22 | — | — | US | disclosed |
| US-20170105972-A1 | SOFT CHEWABLE PHARMACEUTICAL PRODUCTS | INTERVET, INC. (US) | 2017-04-20 | — | — | US | disclosed |
| US-20170012221-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2017-01-12 | — | — | US | disclosed |
| WO-2011114099-A1 | PURIFICATION TAGS OF SYNTHETIC PEPTIDES AND PROTEINS | ALMAC SCIENCES (SCOTLAND) LIMITED (GB) | 2011-09-22 | — | — | WO | disclosed |
| US-7098215-B2 | Nitrogenous compounds and antiviral drugs containing the same | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 2006-08-29 | — | — | US | disclosed |
| US-20040157818-A1 | Cxcr4-antagonistic drugs composed of nitrogen-containing compound | KUREHA CORPORATION (JP) | 2004-08-12 | — | — | US | disclosed |
| US-20040092556-A1 | Nitrogenous compounds and antiviral drugs containing the same | KUREHA CORPORATION (JP) | 2004-05-13 | — | — | US | disclosed |
| EP-1389460-A1 | CXCR4-ANTAGONISTIC DRUGS COMPRISING NITROGEN-CONTAINING COMPOUND | Kureha Chemical Industry Co., Ltd. (JP) | 2004-02-18 | — | — | EP | disclosed |
| EP-1273571-A1 | NITROGENOUS COMPOUNDS AND ANTIVIRAL DRUGS CONTAINING THE SAME | Kureha Chemical Industry Co., Ltd. (JP) | 2003-01-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092556-A1 | Nitrogenous compounds and antiviral drugs containing the same | NSUN2, ZC3HAV1L, PNP | MEN1 3048/4885KMT2A 3470/4885SMN1; SMN2 2044/4885 |
| US-11329230-B2 | Organic light-emitting device | EML4, SUN2, TRPA1 | MEN1 2816/4885KMT2A 1971/4885SMN1; SMN2 4133/4885 |
| US-11179372-B2 | Isoxazoline solution containing vitamin E for use with sanitized drinking water | PROC, EPX, CYP27B1 | MEN1 4113/4885KMT2A 2957/4885SMN1; SMN2 3282/4885 |
| US-11690289-B2 | Organic compound containing heterocyclic ring and having low lumo properties, and organic electroluminescent device using the same | LEF1, PPOX, LIMK1 | MEN1 1500/4885KMT2A 1677/4885SMN1; SMN2 3103/4885 |
| US-20170012221-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | EPCAM, SLC39A3, L1CAM | MEN1 1788/4885KMT2A 2473/4885SMN1; SMN2 4287/4885 |
| US-20170105972-A1 | SOFT CHEWABLE PHARMACEUTICAL PRODUCTS | PAM, TAS2R46, TAS2R16 | MEN1 442/4885KMT2A 838/4885SMN1; SMN2 510/4885 |
| US-11712416-B2 | Solid oral pharmaceutical compositions for isoxazoline compounds | CYP3A7, SI, CYP2A7 | MEN1 4505/4885KMT2A 2112/4885SMN1; SMN2 899/4885 |
| US-20230320981-A1 | SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS | CYP3A7, SI, CYP2A7 | MEN1 4505/4885KMT2A 2112/4885SMN1; SMN2 899/4885 |
| US-20040157818-A1 | Cxcr4-antagonistic drugs composed of nitrogen-containing compound | CXCR4, CXCR1, CXCR2 | MEN1 2191/4885KMT2A 4302/4885SMN1; SMN2 3026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.